HR 3546
Official Title: To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.
Introduced: 05/21/2025
Passed House:
Passed Senate:
To President:
Became Law:
Summary:
Action(s):
- 05/21/2025 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 05/21/2025 - Introduced in House
Bill Details
-
Prescription Drug Price Relief Act of 2025
-
House
-
Congress Number: 119
